{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:09:12Z","timestamp":1757617752051,"version":"3.44.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82360603","82360603"],"award-info":[{"award-number":["82360603","82360603"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"DOI":"10.1007\/s12013-025-01746-x","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T13:21:53Z","timestamp":1744723313000},"page":"3677-3692","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Computational Identification and Validation of Metabolic Cell Death-Related Prognostic Biomarkers for Personalized Treatment Strategies in Prostate Cancer"],"prefix":"10.1007","volume":"83","author":[{"given":"Shixian","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chadanfeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiming","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunhui","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hairong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,11]]},"reference":[{"issue":"4","key":"1746_CR1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.7196\/SAMJ.2024.v114i4.1950","volume":"114","author":"B Marais","year":"2024","unstructured":"Marais, B., Klopper, G., & John, J. (2024). Prostate cancer perspective: Africa versus the world. South African Medical Journal, 114(4), 21\u201325.","journal-title":"South African Medical Journal"},{"issue":"1","key":"1746_CR2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/bju.16178","volume":"133","author":"M Jalloh","year":"2024","unstructured":"Jalloh, M., Cassell, A., Niang, L., & Rebbeck, T. (2024). Global viewpoints: Updates on prostate cancer in Sub\u2010Saharan Africa. BJU International, 133(1), 6\u201313.","journal-title":"BJU International"},{"key":"1746_CR3","volume-title":"Global Cancer Observatory: Cancer Today","author":"J Ferlay","year":"2020","unstructured":"Ferlay, J., Ervik, M., Lam, F., Colombet, M., Mery, L., Pi\u00f1eros, M., Znaor, A., Soerjomataram, I., & Bray, F. (2020). Global Cancer Observatory: Cancer Today. (International Agency for Research on Cancer."},{"issue":"2","key":"1746_CR4","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.eururo.2023.04.021","volume":"84","author":"O Bergengren","year":"2023","unstructured":"Bergengren, O., Pekala, K. R., Matsoukas, K., Fainberg, J., Mungovan, S. F., Bratt, O., Bray, F., Brawley, O., Luckenbaugh, A. N., Mucci, L., & Morgan, T. M. (2023). 2022 update on prostate cancer epidemiology and risk factors\u2014a systematic review. European Urology, 84(2), 191\u2013206.","journal-title":"European Urology"},{"key":"1746_CR5","doi-asserted-by":"publisher","first-page":"100225","DOI":"10.1016\/j.ctarc.2020.100225","volume":"26","author":"C Jacklin","year":"2021","unstructured":"Jacklin, C., Philippou, Y., Brewster, S. F., & Bryant, R. J. (2021). \u201cMore men die with prostate cancer than because of it\u201d-an old adage that still holds true in the 21st century. Cancer Treatment and Research Communications, 26, 100225.","journal-title":"Cancer Treatment and Research Communications"},{"issue":"1","key":"1746_CR6","first-page":"7","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel, R. L., Miller, K. D., Fuchs, H. E., & Jemal, A. (2021). Cancer statistics, 2021. CA: A Cancer Journal for Clinicians, 71(1), 7\u201333.","journal-title":"CA: A Cancer Journal for Clinicians"},{"issue":"1","key":"1746_CR7","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.sxmr.2021.03.001","volume":"10","author":"MM Muermann","year":"2022","unstructured":"Muermann, M. M., & Wassersug, R. J. (2022). Prostate cancer from a sex and gender perspective: A review. Sexual Medicine Reviews, 10(1), 142\u2013154.","journal-title":"Sexual Medicine Reviews"},{"issue":"1","key":"1746_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-021-02230-y","volume":"20","author":"SW Merriel","year":"2022","unstructured":"Merriel, S. W., Pocock, L., Gilbert, E., Creavin, S., Walter, F. M., Spencer, A., & Hamilton, W. (2022). Systematic review and meta-analysis of the diagnostic accuracy of prostate-specific antigen (PSA) for the detection of prostate cancer in symptomatic patients. BMC Medicine, 20(1), 54.","journal-title":"BMC Medicine"},{"issue":"4","key":"1746_CR9","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1016\/j.sjbs.2020.02.003","volume":"27","author":"AM Nassir","year":"2020","unstructured":"Nassir, A. M. (2020). A piece in prostate cancer puzzle: Future perspective of novel molecular signatures. Saudi Journal of Biological Sciences, 27(4), 1148\u20131154.","journal-title":"Saudi Journal of Biological Sciences"},{"issue":"21","key":"1746_CR10","doi-asserted-by":"publisher","first-page":"3350","DOI":"10.3390\/diagnostics13213350","volume":"13","author":"J-Y Chen","year":"2023","unstructured":"Chen, J.-Y., Wang, P.-Y., Liu, M.-Z., Lyu, F., Ma, M.-W., Ren, X.-Y., & Gao, X. S. (2023). Biomarkers for prostate cancer: From diagnosis to treatment. Diagnostics (Basel), 13(21), 3350.","journal-title":"Diagnostics (Basel)"},{"issue":"1","key":"1746_CR11","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s40164-023-00444-9","volume":"12","author":"GL Varaprasad","year":"2023","unstructured":"Varaprasad, G. L., Gupta, V. K., Prasad, K., Kim, E., Tej, M. B., Mohanty, P., Verma, H. K., Raju, G., Bhaskar, L., & Huh, Y. S. (2023). Recent advances and future perspectives in the therapeutics of prostate cancer. Experimental Hematology & Oncology, 12(1), 80.","journal-title":"Experimental Hematology & Oncology"},{"issue":"3","key":"1746_CR12","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.euo.2021.02.008","volume":"4","author":"A Erickson","year":"2021","unstructured":"Erickson, A., Hayes, A., Rajakumar, T., Verrill, C., Bryant, R. J., Hamdy, F. C., Wedge, D. C., Woodcock, D. J., Mills, I. G., & Lamb, A. D. (2021). A systematic review of prostate cancer heterogeneity: Understanding the clonal ancestry of multifocal disease. European Urology Oncology, 4(3), 358\u2013369.","journal-title":"European Urology Oncology"},{"key":"1746_CR13","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.canlet.2021.10.012","volume":"524","author":"NJ del","year":"2022","unstructured":"del, N. J., Flores-T\u00e9llez, T., & Baena, E. (2022). Experimental challenges to modeling prostate cancer heterogeneity. Cancer Letters, 524, 194\u2013205.","journal-title":"Cancer Letters"},{"issue":"4","key":"1746_CR14","doi-asserted-by":"publisher","first-page":"655","DOI":"10.3390\/genes13040655","volume":"13","author":"MM Khan","year":"2022","unstructured":"Khan, M. M., Mohsen, M. T., Malik, M. Z., Bagabir, S. A., Alkhanani, M. F., Haque, S., Serajuddin, M., & Bharadwaj, M. (2022). Identification of potential key genes in prostate cancer with gene expression, pivotal pathways and regulatory networks analysis using integrated bioinformatics methods. Genes (Basel), 13(4), 655.","journal-title":"Genes (Basel)"},{"key":"1746_CR15","doi-asserted-by":"publisher","first-page":"809","DOI":"10.3389\/fonc.2020.00809","volume":"10","author":"S Liu","year":"2020","unstructured":"Liu, S., Wang, W., Zhao, Y., Liang, K., & Huang, Y. (2020). Identification of potential key genes for pathogenesis and prognosis in prostate cancer by integrated analysis of gene expression profiles and the cancer genome atlas. Frontiers in Oncology, 10, 809.","journal-title":"Frontiers in Oncology"},{"issue":"1","key":"1746_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26840-5","volume":"12","author":"M Bolis","year":"2021","unstructured":"Bolis, M., Bossi, D., Vallerga, A., Ceserani, V., Cavalli, M., Impellizzieri, D., Di Rito, L., Zoni, E., Mosole, S., Elia, A. R., Rinaldi, A., Pereira Mestre, R., D'Antonio, E., Ferrari, M., Stoffel, F., Jermini, F., Gillessen, S., Bubendorf, L., Schraml, P., & Theurillat, J. P. (2021). Dynamic prostate cancer transcriptome analysis delineates the trajectory to disease progression. Nature Communications, 12(1), 7033.","journal-title":"Nature Communications"},{"issue":"1","key":"1746_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-85502-4","volume":"15","author":"FM Aldakheel","year":"2025","unstructured":"Aldakheel, F. M., Alnajran, H., Mateen, A., Alduraywish, S. A., Alqahtani, M. S., & Syed, R. (2025). Comprehensive computational analysis of differentially expressed miRNAs and their influence on transcriptomic signatures in prostate cancer. Scientific Reports, 15(1), 3646.","journal-title":"Scientific Reports"},{"key":"1746_CR18","doi-asserted-by":"publisher","first-page":"598801","DOI":"10.3389\/fonc.2020.598801","volume":"10","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y., Zhang, R., Liang, F., Zhang, L., & Liang, X. (2020). Identification of metabolism-associated prostate cancer subtypes and construction of a prognostic risk model. Frontiers in Oncology, 10, 598801.","journal-title":"Frontiers in Oncology"},{"issue":"11","key":"1746_CR19","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1055\/a-2330-3696","volume":"56","author":"D Wang","year":"2024","unstructured":"Wang, D., Pan, H., Cheng, S., Huang, Z., Shi, Z., Deng, H., Yang, J., Jin, C., & Dai, J. (2024). Construction and validation of a prognostic model based on mitochondrial genes in prostate cancer. Hormone and Metabolic Research, 56(11), 807\u2013817.","journal-title":"Hormone and Metabolic Research"},{"issue":"5","key":"1746_CR20","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.7150\/jca.38173","volume":"11","author":"R Yang","year":"2020","unstructured":"Yang, R., Du, Y., Wang, L., Chen, Z., & Liu, X. (2020). Weighted gene co-expression network analysis identifies CCNA2 as a treatment target of prostate cancer through inhibiting cell cycle. Journal of Cancer, 11(5), 1203\u20131211.","journal-title":"Journal of Cancer"},{"issue":"1","key":"1746_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-022-01410-w","volume":"15","author":"M Liu","year":"2022","unstructured":"Liu, M., Chen, M. Y., Huang, J. M., Liu, Q., Wang, L., Liu, R., Yang, N., Huang, W. H., & Zhang, W. (2022). LncRNA weighted gene co-expression network analysis reveals novel biomarkers related to prostate cancer metastasis. BMC Medical Genomics, 15(1), 256.","journal-title":"BMC Medical Genomics"},{"issue":"9","key":"1746_CR22","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1038\/s41416-021-01435-5","volume":"125","author":"F Ahmad","year":"2021","unstructured":"Ahmad, F., Cherukuri, M. K., & Choyke, P. L. (2021). Metabolic reprogramming in prostate cancer. British Journal of Cancer, 125(9), 1185\u20131196.","journal-title":"British Journal of Cancer"},{"issue":"12","key":"1746_CR23","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.3390\/biomedicines9121942","volume":"9","author":"E Iessi","year":"2021","unstructured":"Iessi, E., Vona, R., Cittadini, C., & Matarrese, P. (2021). Targeting the interplay between cancer metabolic reprogramming and cell death pathways as a viable therapeutic path. Biomedicines, 9(12), 1942.","journal-title":"Biomedicines"},{"issue":"2","key":"1746_CR24","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3390\/metabo13020183","volume":"13","author":"UR Wanjari","year":"2023","unstructured":"Wanjari, U. R., Mukherjee, A. G., Gopalakrishnan, A. V., Murali, R., Dey, A., Vellingiri, B., & Ganesan, R. (2023). Role of metabolism and metabolic pathways in prostate cancer. Metabolites, 13(2), 183.","journal-title":"Metabolites"},{"issue":"9","key":"1746_CR25","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1093\/procel\/pwae003","volume":"15","author":"C Mao","year":"2024","unstructured":"Mao, C., Wang, M., Zhuang, L., & Gan, B. (2024). Metabolic cell death in cancer: Ferroptosis, cuproptosis, disulfidptosis, and beyond. Protein Cell, 15(9), 642\u2013660.","journal-title":"Protein Cell"},{"key":"1746_CR26","doi-asserted-by":"publisher","unstructured":"Zhang H., Tang S. (2021). Metabolic reprogramming and cancer precision medicine: A narrative review. Precis Cancer Med, 4. https:\/\/doi.org\/10.21037\/pcm-21-27.","DOI":"10.21037\/pcm-21-27"},{"issue":"6","key":"1746_CR27","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3390\/metabo11060402","volume":"11","author":"J Jiang","year":"2021","unstructured":"Jiang, J., Batra, S., & Zhang, J. (2021). Asparagine: a metabolite to be targeted in cancers. Metabolites, 11(6), 402.","journal-title":"Metabolites"},{"key":"1746_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000541881","volume":"9","author":"R Novysedlak","year":"2024","unstructured":"Novysedlak, R., Guney, M., Al Khouri, M., Bartolini, R., Koumbas Foley, L., Benesova, I., Ozaniak, A., Novak, V., Vesely, S., Pacas, P., Buchler, T., & Ozaniak Strizova, Z. (2024). The immune microenvironment in prostate cancer: a comprehensive review. Oncology, 9, 1\u201337.","journal-title":"Oncology"}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-025-01746-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12013-025-01746-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-025-01746-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T08:22:26Z","timestamp":1757146946000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12013-025-01746-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,11]]},"references-count":28,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["1746"],"URL":"https:\/\/doi.org\/10.1007\/s12013-025-01746-x","relation":{},"ISSN":["1559-0283"],"issn-type":[{"type":"electronic","value":"1559-0283"}],"subject":[],"published":{"date-parts":[[2025,4,11]]},"assertion":[{"value":"26 March 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki (2013) and the Declaration of Istanbul (2018) and was approved by the Ethics Committee of The Second Affiliated Hospital of Kunming Medical University. All participants provided informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}}]}}